key: cord-0052841-1e2blzey
authors: Rasmussen, Sonja A.; Jamieson, Denise J.
title: COVID-19 and Pregnancy - Reply
date: 2020-11-17
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.11.021
sha: ea9d7e906a6594996016bb5ea4098214622be6a1
doc_id: 52841
cord_uid: 1e2blzey

nan

We appreciate the interest in our work and the opportunity to respond to the issues raised by Volpato et al. 1 Since the publication of our paper online on February 24, 2020, 2 data from many additional studies have been published addressing the effects of COVID-19 on the pregnant woman and her fetus. For example, updates on surveillance data from the United States on COVID-19 and pregnancy were recently published: these data show that among over 400,000 women of childbearing age with symptomatic COVID-19, pregnant women were more likely to be admitted to an intensive care unit, to require invasive ventilation, to receive extracorporeal membrane oxygenation (ECMO), and to die than nonpregnant women. 3 Infants born to these women also appear to be at increased risk: among nearly 4,000 infants born to women with COVID-19 during pregnancy in 16 jurisdictions in the United States, infants born to SARS-CoV-2-infected women were more likely to be born preterm (12.9% were preterm, compared to a national estimate of 10.2%). 4 These data are consistent with a large systematic review that suggests that infants born to mothers with COVID-19 are at a 3-fold increased risk of preterm birth and of neonatal intensive care unit admission. 5 These findings emphasize the importance of implementation of COVID-19 prevention measures in pregnant women, as well as the importance of collecting data on SARS-CoV-2-infected pregnant women and their infants.

References:

Volpato F, dos Santos LG, dos Santos EM. Coronavirus and its controversial results during pregnancy. Am J Obstet Gynecol. 2020;in this issue.

2.

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy -SET-NET, 16 Jurisdictions

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis